DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
KEY PRODUCTS
Reset all filters
01 1Dr. Reddy's Laboratories
Reset all filters
01 1PIOGLITAZONE HYDROCHLORIDE USP
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Complete
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-14
Pay. Date : 2013-12-31
DMF Number : 21295
Submission : 2008-01-31
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is PIOGLITAZONE HYDROCHLORIDE USP, with a corresponding US DMF Number 21295.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on December 31, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II